pharmaphorum

AZ and Daiichi's TROP2 ADC shows promise in first-line lung cancer

Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
pharmaphorum

FDA gives AbbVie's c-Met lung cancer ADC a breakthrough tag

The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V ...
Yahoo Finance

Analog Devices, Inc. (ADI)

AMD Advanced Micro Devices, Inc.
Simon Fraser University

Finite Difference Approximations of Derivatives

First-order derivatives: n additional function calls are needed. Second-order derivatives based on gradient calls, when the "grd" module is specified (Dennis and Schnabel 1983): n additional gradient ...